EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Treg and Oxidative Stress Biomarker Profiles in Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Yana Todorova iD, Radostina Dimitrova, Teodora Kalfova iD, Steliyan Petrov iD, Martina Bozhkova iD, Mariya Ivanovska iD, Dobrina Dudova, Mariana Murdjeva iD, Hristo Taskov iD, Michael Maes, Maria Nikolova

International Journal of Molecular Sciences · 22.10.2026 · 27 (21) · 9422

DOI: 10.3390/ijms27219422 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 22.10.2026. Verfasst von Yana Todorova und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center of Competence Immunopathogen, National Center of Infectious and Parasitic Diseases (NCIPD), 1504 Sofia, Bulgaria. Hauptthemen laut MEDLINE: Fatigue Syndrome, Chronic, Oxidative Stress, COVID-19, T-Lymphocytes, Regulatory. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Program "Research, Innovation and Digitalization for Smart Transformation 2021 - 2027""Center of Competence ImmunoPathogen".

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic immune dysregulation is the possible pathophysiological mechanism in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and long coronavirus infectious disease (long COVID, LC). However, a detailed characterization of regulatory and effector T-cell subsets in these conditions remains limited. To assess and compare T-cell subsets in relation to serum biomarkers of chronic activation and oxidative/nitrosative stress in an attempt to differentiate between LC and ME/CFS patients. Peripheral blood mononuclear cells (PMNC) from LC patients (n = 89), ME/CFS patients (n = 125), and healthy controls (HC, n = 80) were analyzed using multiparameter flow cytometry. The frequencies of naïve (CD45RA+), effector (CD45RA-), CD31+, CD39+, CD73+, GARP+, PI16+, CD15s/CD161+, and CD147+ Treg subsets were determined in relation to CD4+ and CD8+ T-cell differentiation, activation, and effector subsets. Catalase (CAT), superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPX1), malondialdehyde (MDA), nitric oxide synthase 1 and 3 (NOS1, NOS3), zonulin, lipopolysaccharide (LPS), immunoglobulin G (IgG) against lipopolysaccharide (IgG-LPS), Toll-like receptor 4 (TLR4), indoleamine 2,3-dioxygenase (IDO), and Dickkopf-related protein 1 (DKK1) were measured in serum by ELISA. Clinical symptom scores (HAMA, HAMD, FF, dePol) were additionally assessed. The immune-serum biomarkers distinguishing LC, ME/CFS, and HC comprised Th17, CD15s+CD161−eTreg, and CD161+ Treg. The five-marker signature retained significance after adjustment for age, BMI, and sex. Altered T-cell subsets were strongly associated with markers of oxidative (GPX1) and nitrosative (NOS3) stress but not directly with symptom severity. ME/CFS showed a strong separation from HC across Random Forest (AUC = 0.907) and logistic regression (AUC = 0.924). The modest distinction of LC from HC (AUC = 0.727 and 0.577 respectively) possibly reflected important endotypic diversity, though differences in disease duration, vaccination history, biomarker selection, and other cohort characteristics might add to it. MDA was an independent predictor for three-class classification, ME/CFS vs. HC, and LC vs. HC pairwise comparisons, while GPX1 discriminated between ME/CFS and LC. In spite of shared biomarkers of oxidative stress and T-cell response dysregulation, our results support the hypothesis that LC and ME/CFS differ in the extent of cellular damage and the exhaustion of compensatory mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fatigue Syndrome, ChronicOxidative StressCOVID-19T-Lymphocytes, RegulatoryCoronavirus InfectionsHumansBiomarkersPost-Acute COVID-19 SyndromeFemaleMaleAdultMiddle AgedSARS-CoV-2Betacoronavirus

Stichwörter der Autor:innen

GPX1MDAME/CFSTh17Treglong COVID

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Center of Competence Immunopathogen, National Center of Infectious and Parasitic Diseases (NCIPD), 1504 Sofia, Bulgaria.
  • Research and Innovation Program for the Development of MU-PLOVDIV (SRIPD-MUP), Creation of a Network of Research Higher Schools, National Plan for Recovery and Sustainability, EuropeanUnion-NextGenerationEU, Medical Uni…
  • Department of Medical Microbiology and Immunology "Elissay Yanev", Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.
  • Research Institute, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.
  • Department of Microbiology and Virology, Medical University of Pleven, 5800 Pleven, Bulgaria.
  • Institute of Innovation and Smart Technology, University of Telecommunication and Posts, 1700 Sofia, Bulgaria.

ORCID-Profile: Yana Todorova, Teodora Kalfova, Steliyan Petrov, Martina Bozhkova, Mariya Ivanovska, Mariana Murdjeva, Hristo Taskov

Förderung

  • Program "Research, Innovation and Digitalization for Smart Transformation 2021 - 2027""Center of Competence ImmunoPathogen"

Zitieren

APA

Todorova, Y., Dimitrova, R., Kalfova, T., Petrov, S., Bozhkova, M., Ivanovska, M., Dudova, D., Murdjeva, M., Taskov, H., Maes, M., & Nikolova, M. (2026). Treg and Oxidative Stress Biomarker Profiles in Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. International Journal of Molecular Sciences, 27(21), 9422. https://doi.org/10.3390/ijms27219422

Vancouver

Todorova Y, Dimitrova R, Kalfova T, Petrov S, Bozhkova M, Ivanovska M, et al. Treg and Oxidative Stress Biomarker Profiles in Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. International Journal of Molecular Sciences. 2026;27(21):9422. doi:10.3390/ijms27219422

BibTeX
@article{Todorova2026,
  author = {Todorova, Yana and Dimitrova, Radostina and Kalfova, Teodora and Petrov, Steliyan and Bozhkova, Martina and Ivanovska, Mariya and Dudova, Dobrina and Murdjeva, Mariana and Taskov, Hristo and Maes, Michael and Nikolova, Maria},
  title = {Treg and Oxidative Stress Biomarker Profiles in Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {21},
  pages = {9422},
  doi = {10.3390/ijms27219422}
}
Kostenlos starten →